New #Myositis research: 38.8% discordance between patient & physician disease activity assessments, highest in#IBM. #PROMIS cutoffs may enable better remote monitoring—critical since patients reporting higher disease activity often have poorer outcomes. tinyurl.com/mrxumb73

tinyurl.com/mrxumb73

Very pleased to share that our first paper from the @EULAR_org #SocialMedia Study Group is now published!
This Declaration underpins the foundational principles for embracing SoMe in #rheumatology
💡Evidence-base, patient dignity & inclusive dialogue tinyurl.com/3h3n7cbv
@loreto-carmona.bsky.social

Our new editorial on Classification in #Myositis
A striking paradox: 17+ classification criteria since 1975, yet still no consensus. The field evolves faster than we can develop robust frameworks - by the time criteria are published, the science has moved on.
tinyurl.com/2uv2pkn4

NEW Comment—Reasoning large language models in rheumatology: a call for responsible action
bit.ly/3ET1j15 #Medsky #Rheumsky
@vincevenerito.bsky.social @latikagupta.bsky.social

Now in @thelancetrheum.bsky.social-Reasoning LLMs in #Rheumatology: Pearl's ladder of causation shows the gap bw AI's statistical patterns & true counterfactual reasoning that AI fundamentally lacks. tinyurl.com/mrxsrh85re @vincevenerito.bsky.social

Big thanks to IJRD - APLAR Journal for recognizing our work on #pain in #myositis as the most viewed article! Special thanks to the CoVAD Study group for their incredible efforts!

Such a pleasure to work with this wonderful team during our time at #EV2025🇩🇰, including @maryg147.bsky.social, on resources for unplanned pregnancy in inflammatory rheumatic disease.